Mild behavioral impairment (MBI) describes persistent behavioral changes in later life as an at-risk state for dementia. While cardiovascular risk factors (CVRFs) are linked to dementia, it is uncertain how CVRFs are associated with MBI.
Objective:
To determine the prevalence of MBI and its association with CVRFs among cognitively normal (CN) and mild cognitive impairment (MCI) individuals in Singapore.
Methods:
172 individuals (79 CN and 93 MCI) completed the MBI-checklist (MBI-C). The prevalence of MBI and MBI-C sub-domain characteristics among CN and MCI were examined. Regression models evaluated the relationships between MBI-C sub-domain scores with CVRFs.
Results:
The prevalence of MBI and mean MBI-C total score were significantly higher among MCI than CN (34.4%versus 20.3%, p = 0.022 and 7.01 versus 4.12, p = 0.04). The highest and lowest-rated sub-domains among CN and MCI were impulse dyscontrol and abnormal thoughts and perception respectively. Within the MCI cohort, a higher proportion of individuals with diabetes mellitus (DM) had MBI compared to individuals without DM (28.1%versus 10.4%, p = 0.025). The interaction of DM and MCI cohort resulted in significantly higher mean MBI-C total, decreased motivation, emotional dysregulation, impulse dyscontrol, and abnormal thoughts and perception sub-domain scores.
Conclusion:
The prevalence of MBI is higher among a Singapore cohort compared to Caucasian cohorts. The associations of DM with both the presence and severity of MBI among MCI suggest that DM may be a risk factor for MBI. The optimization of DM may be a potential therapeutic approach to improve clinical outcomes among MCI with MBI.
LussierFZ, PascoalTA, ChamounM, TherriaultJ, TissotC, SavardM, KangMS, MathotaarachchiS, BenedetAL, ParsonsM, QureshiMNI, ThomasÉM, ShinM, DionLA, MassarwehG, SoucyJP, TsaiIH, VitaliP, IsmailZ, Rosa-NetoP, GauthierS (2020) Mild behavioral impairment is associated with β-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals. Alzheimers Dement16, 192–199.
4.
WiseEA, RosenbergPB, LyketsosCG, LeoutsakosJM (2019) Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer’s Coordinating Centers volunteers. Alzheimers Dement (Amst)11, 333–339.
5.
IsmailZ, Agüera-OrtizL, BrodatyH, CieslakA, CummingsJ, FischerCE, GauthierS, GedaYE, HerrmannN, KanjiJ, LanctôtKL, MillerDS, MortbyME, OnyikeCU, RosenbergPB, SmithEE, SmithGS, SultzerDL, LyketsosC (2017) The Mild Behavioral Impairment Checklist (MBI-C): A rating scale for neuropsychiatric symptoms in pre-dementia populations. J Alzheimers Dis56, 929–938.
6.
MonasteroR, MangialascheF, CamardaC, ErcolaniS, CamardaR (2009) A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis18, 11–30.
7.
RouseHJ, SmallBJ, SchinkaJA, LoewensteinDA, DuaraR, PotterH (2021) Mild behavioral impairment as a predictor of cognitive functioning in older adults. Int Psychogeriatr33, 285–293.
8.
SheikhF, IsmailZ, MortbyME, BarberP, CieslakA, FischerK, GrangerR, HoganDB, MackieA, MaxwellCJ, MenonB, MuellerP, PatryD, PearsonD, QuickfallJ, SajobiT, TseE, WangM, SmithEE (2018) Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden. Int Psychogeriatr30, 233–244.
9.
FanS, LIangX, YunT, PeiZ, HuB, IsmailZ, YangZ, XuF (2020) Mild behaviour impairment is related to frailty in cognitively normal older adults: A cross-sectional study. BMC Geriatr20, 510.
10.
RaoAR, ChatterjeeP, ThakralM, DwivediSN, DeyAB (2020) Behavioural issues in late life may be the precursor of dementia- A cross sectional evidence from memory clinic of AIIMS, India. PLoS One15, e023451.
11.
CreeseB, GriffithsA, BrookerH, CorbettA, AarslandD, BallardC, IsmailZ (2020) Profile of mild behavioral impairment and factor structure of the Mild Behavioral Impairment Checklist in cognitively normal older adults. Int Psychogeriatr32, 705–717.
12.
MalloSC, IsmailZ, PereiroAX, FacalD, Lojo-SeoaneC, Campos-MagdalenoM, Juncos-RabadánO (2019) Assessing mild behavioral impairment with the mild behavioral impairment checklist in people with subjective cognitive decline. Int Psychogeriatr31, 231–239.
13.
MalloSC, IsmailZ, PereiroAX, FacalD, Lojo-SeoaneC, Campos-MagdalenoM, Juncos-RabadánO (2018) Assessing mild behavioral impairment with the Mild Behavioral Impairment-Checklist in people with mild cognitive impairment. J Alzheimers Dis66, 83–95.
14.
MatsuokaT, IsmailZ, NarumotoJ (2019) Prevalence of mild behavioral impairment and risk of dementia in a psychiatric outpatient clinic. J Alzheimers Dis70, 503–511.
15.
HallJR, WiechmannAR, JohnsonLA, EdwardsM, BarberRC, CunninghamR, SinghM, O’BryantSE, DoodyR, RoundtreeS, PavlikV, ChanW, MassmanP, DarbyE, EvansT, WilliamsB, SchrimsherG, DentinoA, OrozcoR, FairchildT, KneblJ, MainsD, AlvarezL, AdamsP, RosenbergR, WeinerM, QuicenoM, ReischJ, HuebingerR, XiaoG, SvetlikD, WerryA, SmithJ, RoyallD, PalmerR, PolkM (2014) Total cholesterol and neuropsychiatric symptoms in Alzheimer’s disease: The impact of total cholesterol level and gender. Dement Geriatr Cogn Disord38, 300–309.
16.
ShiQ, ZhouF, MeiJ, YangH, LiH (2020) The effect of type 2 diabetes mellitus on neuropsychological symptoms in Chinese early Alzheimer’s disease population. Neuropsychiatr Dis Treat16, 829–836.
17.
HwangI, BaekK-H, HanJH, HaS-W, YangY (2017) Hypertension and neuropsychiatric symptoms in patients with drug-naïve Alzheimer’s disease. Dement Neurocogn Disord16, 78.
18.
KortebiI, KaramehW, KumarS, GallagherD, GolasA, SchweizerT, MunozD, BarfettJ, ButtersM, BowieCR, FlintA, RajjiT, HerrmannN, PollockB, MulsantB, MahL, FischerCE (2019) Examining the impact of cardiovascular risk factors on neuropsychiatric symptoms in the PACT-MD study. Am J Geriatr Psychiatry27, S202–S203.
19.
FischerCE, KortebiI, KaramehWK, KumarS, GallagherD, GolasA, MunozD, BarfettJ, ButtersMA, BowieCR, FlintA, RajjiT, HerrmannN, PollockBG, MulsantB, SchweizerTA, MahL (2019) Examining the link between cardiovascular risk factors and neuropsychiatric symptoms in mild cognitive impairment and major depressive disorder in remission. J Alzheimers Dis67, 1305–1311.
20.
PetersenRC, SmithGE, WaringSC, IvnikRJ, KokmenE, TangelosEG (1997) Aging, memory, and mild cognitive impairment. Int Psychogeriatr9, 65–69.
21.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
22.
FengL, ChongMS, LimWS, NgTP (2012) The modified mini-mental state examination test: Normative data for Singapore Chinese older adults and its performance in detecting early cognitive impairment. Singapore Med J53, 458–462.
23.
NasreddineZS, PhillipsNA, BédirianV, CharbonneauS, WhiteheadV, CollinI, CummingsJL, ChertkowH (2005) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc53, 695–699.
24.
CreeseB, BrookerH, IsmailZ, WesnesKA, HampshireA, KhanZ, MegalogeniM, CorbettA, AarslandD, BallardC (2019) Mild behavioral impairment as a marker of cognitive decline in cognitively normal older adults. Am J Geriatr Psychiatry27, 823–834.
25.
IsmailZ, ElbayoumiH, FischerCE, HoganDB, MillikinCP, SchweizerT, MortbyME, SmithEE, PattenSB, FiestKM (2017) Prevalence of depression in patients with mild cognitive impairment: A systematic review and meta-analysis. JAMA Psychiatry74, 58–67.
26.
ChenJ, ChenH (2002) Best practice. West J Med176, 239–244.
27.
FuhJL, LamL, HironoN, SenanarongV, CummingsJL (2006) Neuropsychiatric inventory workshop: Behavioral and psychologic symptoms of dementia in Asia. Alzheimer Dis Assoc Disord20, 314–317.
28.
KramerEJ, KwongK, LeeE, ChungH (2002) Culture and medicine cultural factors influencing the mental. West J Med176, 227–231.
29.
BrackeP, PattynE, Vondem Knesebeck O (2013) Overeducation and depressive symptoms: Diminishing mental health returns to education. Sociol Health Illn35, 1242–1259.
30.
MortbyME, IsmailZ, AnsteyKJ (2018) Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults. Int Psychogeriatr30, 221–232.
31.
ChengST (2017) Dementia caregiver burden: A research update and critical analysis. Curr Psychiatry Rep19, 64.
32.
TengE, LuPH, CummingsJL (2007) Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer’s disease. Dement Geriatr Cogn Disord24, 253–259.
33.
SaariT, SmithEE, IsmailZ (2021) Network analysis of impulse dyscontrol in mild cognitive impairment and subjective cognitive decline. Int Psychogeriatr, doi: 10.1017/S1041610220004123.
KruseJ, SchmitzN, ThefeldW (2003) On the association between diabetes. Diabetes Care26, 1841–1846.
36.
KotaS, MeherL, JammulaS, KrishnaSVS, KotaS, ModiK (2012) Neuropsychiatric screening in type 2 diabetes mellitus. Indian J Endocrinol Metab16, 37.
37.
SommerfieldAJ, DearyIJ, FrierBM (2004) Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care27, 2335–2340.
38.
EckstrandKL, MummareddyN, KangH, CowanR, ZhouM, ZaldD, SilverHJ, NiswenderKD, AvisonMJ (2017) An insulin resistance associated neural correlate of impulsivity in type 2 diabetes mellitus. PLoS One12, e0189113.
39.
DietlinS, SotoM, KiyasovaV, PueyoM, De MauleonA, DelrieuJ, OussetPJ, VellasB (2019) Neuropsychiatric symptoms and risk of progression to Alzheimer’s disease among mild cognitive impairment subjects. J Alzheimers Dis70, 25–34.
40.
RadSK, AryaA, KarimianH, MadhavanP, RizwanF, KoshyS, PrabhuG (2018) Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: Link between type 2 diabetes and Alzheimer’s disease. Drug Des Devel Ther12, 3999–4021.
41.
GonçalvesRA, WijesekaraN, FraserPE, De FeliceFG (2019) The link between tau and insulin signaling: Implications for Alzheimer’s disease and other tauopathies. Front Cell Neurosci13, 17.
42.
KimH-G (2019) Cognitive dysfunctions in individuals with diabetes mellitus. Yeungnam Univ J Med36, 183–191.
43.
KleinriddersA, CaiW, CappellucciL, GhazarianA, CollinsWR, VienbergSG, PothosEN, KahnCR (2015) Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc Natl Acad Sci U S A112, 3463–3468.
44.
ZhaoZ, Ksiezak-RedingH, RiggioS, HaroutunianV, PasinettiGM (2006) Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction. Schizophr Res84, 1–14.
45.
CuperfainAB, KennedyJL, GonçalvesVF (2020) Overlapping mechanisms linking insulin resistance with cognition and neuroprogression in bipolar disorder. Neurosci Biobehav Rev111, 125–134.
